Ropes & Gray represented Rubicon Founders in the transaction, and Sidley Austin represented Caidya. Rubicon Founders announced its $165 million strategic growth investment in Caidya, a...
Rubicon Founders’ $165 Million Investment in Caidya
J-Pharma’s License Agreement with Georgetown University
Ropes & Gray represented J-Pharma Co. Ltd. in the deal. J-Pharma Co. Ltd. (J-Pharma), a Japanese bio-venture company, announced it entered into an agreement with Georgetown...
LianBio’s License Agreement with Bristol Myers Squibb
Ropes & Gray represented LianBio on the deal. LianBio (Nasdaq: LIAN) announced it has entered into an agreement with Bristol Myers Squibb (NYSE:BMY)(BMS), whereby BMS has obtained...
LianBio’s License Agreement with Pfizer
Ropes & Gray advised LianBio on the deal. Pfizer and LianBio announced on December 19, 2022 that Pfizer has opted in to the right to develop...
LianBio’s $325 Million Initial Public Offering
Zhong Lun and Ropes & Gray advised LianBio on the deal. LianBio executed an initial public offering and listing of American depositary shares on the Nasdaq...